Top 10 Companies in the (S)-N-BOC-4-Bromophenylalanine (CAS 62129-39-9) Market (2026): Market Leaders Powering Global Pharmaceutical Innovation

MARKET INSIGHTS

Global (S)-N-BOC-4-Bromophenylalanine (CAS 62129-39-9) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 54.7 million by 2034, exhibiting a CAGR of 6.9% during the forecast period.

(S)-N-BOC-4-Bromophenylalanine (CAS 62129-39-9) is a protected, enantiopure amino acid derivative widely utilized as a key building block in pharmaceutical synthesis and peptide chemistry. The compound features a tert‑butoxycarbonyl (BOC) protecting group on the amine functionality and a bromine substituent at the para‑position of the phenylalanine aromatic ring, making it particularly valuable in asymmetric synthesis, drug discovery workflows, and the development of novel therapeutic candidates.

The market is witnessing steady growth driven by rising demand for high‑purity chiral intermediates in pharmaceutical research and increasing adoption of peptide‑based therapeutics. The growing pipeline of small‑molecule and peptide drug candidates across oncology, neurology, and metabolic disease indications continues to amplify demand for specialized amino acid building blocks such as this compound. Furthermore, expanding contract research and manufacturing organization (CRMO) activity globally, particularly across North America, Europe, and Asia‑Pacific, is reinforcing procurement of advanced intermediates. Key suppliers operating in this space include Sigma‑Aldrich (Merck KGaA), Bachem AG, and Alfa Aesar, among others.

(S)-N-BOC-4-Bromophenylalanine (CAS 62129-39-9) Market – View in Detailed Research Report

Top 10 Companies in the (S)-N-BOC-4-Bromophenylalanine Market

1. Sigma‑Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany / New Jersey, USA
Key Offering: High‑purity, GMP‑ready BOC‑protected amino acids for pharmaceutical synthesis

Sigma‑Aldrich supplies a broad portfolio of chiral intermediates, with (S)-N‑BOC‑4‑Bromophenylalanine positioned as a premium reagent for peptide‑based drug discovery. Its robust analytical support, including chiral HPLC data and certificates of analysis, ensures consistent batch performance for contract development and manufacturing organizations.

Sustainability and Growth Initiatives:

• Investment in green chemistry protocols for Boc‑protection to reduce solvent usage
• Expansion of GMP‑compliant production lines to meet regulatory demands in the EU and US
• Partnerships with academic institutions to support fragment‑based screening programs

2. TCI Chemicals

Headquarters: Tokyo, Japan
Key Offering: Advanced specialty chemicals for fine‑chemical synthesis

TCI’s expertise in chiral synthesis and scalable production makes it a preferred supplier for research‑grade and commercial‑grade (S)-N‑BOC‑4‑Bromophenylalanine. The company’s focus on high‑purity reagents supports early‑stage medicinal chemistry and peptide‑based pipeline development.

Sustainability and Growth Initiatives:

• Implementation of renewable energy sources in manufacturing facilities
• Development of low‑toxicity solvents for Boc‑protected intermediates
• Collaboration with CROs to provide rapid, on‑demand custom synthesis services

3. Watanabe Chemical Industries

Headquarters: Tokyo, Japan
Key Offering: API and specialty chemical manufacturing with a focus on chiral amino acids

Watanabe delivers high‑purity (S)-N‑BOC‑4‑Bromophenylalanine to pharmaceutical developers seeking reliable chiral building blocks. The company’s process optimization capabilities reduce synthesis time and cost, enhancing competitiveness in the fine‑chemical market.

Sustainability and Growth Initiatives:

• Adoption of continuous flow chemistry for Boc‑protection steps
• Integration of waste‑reduction strategies in chiral resolution processes
• Strategic alliances with European CROs to expand market reach

4. Jinan Chenghui‑Shuangda Chemical Co., Ltd.

Headquarters: Jinan, China
Key Offering: Bulk production of BOC‑protected amino acids for research and industrial use

Jinan Chenghui‑Shuangda provides cost‑effective, high‑purity (S)-N‑BOC‑4‑Bromophenylalanine to a growing base of Chinese and global biotech firms. Its scalable manufacturing platform supports both small‑scale research and large‑scale CDMO projects.

Sustainability and Growth Initiatives:

• Implementation of ISO 14001 environmental management systems
• Use of biodegradable polymers for packaging to reduce plastic waste
• Expansion of domestic R&D centers to accelerate product innovation

5. Suzhou Highfine Biotech Co., Ltd.

Headquarters: Suzhou, China
Key Offering: Specialty BOC‑protected amino acids for peptide synthesis and conjugation chemistry

Su Zhou Highfine Biotech offers a portfolio of high‑purity reagents, including (S)-N‑BOC‑4‑Bromophenylalanine, to support complex peptide assembly and bioconjugation projects. Its strong analytical support and GMP‑aligned production make it a reliable partner for early‑stage drug discovery.

Sustainability and Growth Initiatives:

• Development of water‑based Boc‑protection protocols to lower solvent consumption
• Adoption of closed‑loop recycling for reaction by‑products
• Collaboration with university laboratories to foster academic‑industry partnerships

6. Hangzhou Hairui Chemical Co., Ltd.

Headquarters: Hangzhou, China
Key Offering: High‑purity BOC‑protected amino acids for pharmaceutical and research applications

Hangzhou Hairui delivers (S)-N‑BOC‑4‑Bromophenylalanine with stringent quality control, supporting both academic research and industrial synthesis. The company’s focus on rapid turnaround and comprehensive documentation meets the needs of CROs and CDMOs.

Sustainability and Growth Initiatives:

• Implementation of energy‑efficient manufacturing processes
• Use of recyclable packaging materials for laboratory reagents
• Strategic investment in chiral chromatography infrastructure

7. Activotec Ltd.

Headquarters: London, United Kingdom
Key Offering: Custom synthesis of chiral amino acids for pharmaceutical development

Activotec specializes in on‑demand synthesis of (S)-N‑BOC‑4‑Bromophenylalanine, providing rapid, high‑purity batches for small‑scale research and early‑stage development projects. Its expertise in asymmetric hydrogenation and enzymatic resolution supports a wide range of chiral intermediates.

Sustainability and Growth Initiatives:

• Adoption of low‑toxicity reagents in synthesis routes
• Investment in digital supply chain management to reduce lead times
• Partnerships with UK academic institutions to support bioconjugation research

8. Shaanxi Dideu Medichem Co., Ltd.

Headquarters: Xi’an, China
Key Offering: High‑purity BOC‑protected amino acids for pharmaceutical intermediates

Shaanxi Dideu Medichem supplies (S)-N‑BOC‑4‑Bromophenylalanine to a diverse client base, including CDMOs and research laboratories. Its focus on process optimization and quality assurance ensures consistent product performance.

Sustainability and Growth Initiatives:

• Implementation of waste‑water treatment systems in production facilities
• Use of renewable energy sources for manufacturing operations
• Expansion of custom synthesis capabilities to support niche peptide projects

9. Sichuan Tongsheng Amino Acid Co., Ltd.

Headquarters: Chengdu, China
Key Offering: Bulk production of BOC‑protected amino acids for research and industrial use

Sichuan Tongsheng offers (S)-N‑BOC‑4‑Bromophenylalanine at competitive pricing while maintaining high purity standards. The company’s scalable processes support both small‑scale academic research and large‑scale CDMO production.

Sustainability and Growth Initiatives:

• Adoption of green chemistry principles in Boc‑protection steps
• Implementation of closed‑loop solvent recycling systems
• Strategic investment in advanced chiral chromatography equipment

10. Jinan Chenghui‑Shuangda Chemical Co., Ltd.

Headquarters: Jinan, China
Key Offering: High‑purity BOC‑protected amino acids for pharmaceutical and research applications

Jinan Chenghui‑Shuangda delivers (S)-N‑BOC‑4‑Bromophenylalanine with robust quality control and rapid delivery, supporting a wide range of peptide synthesis projects. Its focus on cost‑effective production makes it a preferred supplier for academic and small‑biotech firms.

Sustainability and Growth Initiatives:

• Implementation of energy‑efficient manufacturing processes
• Use of recyclable packaging materials for laboratory reagents
• Collaboration with local universities to support research initiatives

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/307908/nbocbromophenylalanine-market

Get Full Report Here: https://www.24chemicalresearch.com/reports/307908/nbocbromophenylalanine-market

Market Outlook

The forecast period from 2026 to 2034 indicates a steady expansion of the (S)-N‑BOC‑4‑Bromophenylalanine market, driven by the continued growth of peptide‑based therapeutics and the increasing need for high‑purity chiral intermediates. The emphasis on advanced synthesis techniques and stringent quality controls is expected to sustain demand across the pharmaceutical, biotechnology, and academic sectors.

Future Trends

• Expansion of radiopharmaceutical applications, leveraging the bromine handle for PET tracer development.
• Growth of antibody‑drug conjugates and other bioconjugation platforms that require halogenated amino acids.
• Increased collaboration between academic institutions and industry to accelerate fragment‑based drug discovery.
• Adoption of continuous flow and green chemistry methods to reduce the environmental footprint of Boc‑protected amino acid synthesis.
• Rise in demand for custom, small‑batch synthesis services from CROs and CDMOs.